Chemicals Andrew Liveris

  • LONDON, May 27- Monsanto boss Hugh Grant could land more than $70 million if the world's largest seed company is taken over by German chemicals giant Bayer AG. The U.S. firm said it was open to engaging in further negotiations with Bayer after turning down its $62 billion bid as "incomplete and financially inadequate" this week. That $122- per-share offer would allow...

  • *Net sales fall 13.5 pct to $10.70 bln vs. est $10.66 bln. The merger is expected to create cost synergies of about $3 billion, the companies have said. "We feel very good that $3 billion in synergies we announced in December is a floor, not a ceiling," he told Reuters.

  • April 28- Dow Chemical Co reported a higher-than-expected quarterly adjusted profit as margins rose to their highest level in more than a decade. "We see strong demand signals in North America, gradual recovery in Europe and ongoing sustainable urbanization in China," Dow Chief Executive Andrew Liveris said in a statement. The company's net income fell to $169...

  • Dow CEO Andrew Liveris will get $52.8 million in cash, stock and other payments, including about $40 million he is already entitled to on his retirement, DowDuPont said in a regulatory filing. DuPont's Edward Breen, who replaced Ellen Kullman as CEO in October, will get $27.2 million, DowDuPont said. The news of Liveris's retirement was seen as a victory for Daniel...

  • March 3- DowDuPont, the entity to be created by the merger of DuPont with Dow Chemical Co, said the chief executives of the two companies would get a combined $80 million in "golden parachute" payments after DowDuPont splits into three. Dow CEO Andrew Liveris will get $52.8 million in cash, stock and other payments, while DuPont CEO Edward Breen will get $27.2 million,...

  • *Andrew Liveris orchestrated $130 bln merger with rival DuPont. Feb 2- Dow Chemical's chief executive Andrew Liveris, fresh from orchestrating a $130 billion merger with U.S. rival DuPont, on Tuesday announced plans to retire by mid-2017, a step he takes after years of pitched battles with an activist shareholder unhappy with his leadership.

  • *Q4 earnings/shr 93 cents vs est 70 cents. *Shares up as much as 4 pct at $44.46. Activist investor Daniel Loeb of hedge fund Third Point has been calling for the removal of Liveris from the merged company.

  • *Q4 earnings/shr 93 cents vs est 70 cents. *Shares up as much as 4 pct at $44.46. Dow is targeting an additional $300 million from cost savings in 2016, building on the $345 million it realized last year, Chief Financial Officer Howard Ungerleider said on a post-earnings call.

  • *Q4 earnings/shr 93 cents vs est 70 cents. *Shares up 3.3 pct at $44 premarket. Shares of the company, which is merging with DuPont, were up 3.3 percent at $44 in premarket trading.

  • Dow Dupont

    "I don't think this was a great call by the two boards," contended Jeff Sonnenfeld of the Yale School of Management.

  • Andrew Liveris, chairman and chief executive officer of Dow Chemical Co.

    Former Dow CEO Andrew Liveris is accused of using his position to finance his lifestyle and boosting a charity that burnished his fame in Greece.

  • DOW CEO: Low oil stimulus working

    Our portfolio is built to handle volatility, says Andrew Liveris, Dow Chemical CEO, talking through his company's quarterly results and the impact of low oil prices on the company's bottom line.

  • A big positive sign in this once left-for-dead sector has turned Cramer's attention to a handful of stocks that could go higher.

  • Daniel Loeb

    Jim Cramer is disgusted with the tactics taken by this hedge fund activist.

  • Hedge fund Third Point is considering launching a proxy contest at Dow Chemical after negotiations over board seats broke down on Thursday.

  • Wondering what to do when you think the market is over-extended and are looking for a bargain? Here is Jim Cramer's test for a cheap stock.

  • With the stock at an all-time high and oil at a low, this is what "Mad Money" host Jim Cramer thinks you need to know.

  • Andrew Liveris

    This stock just reported the best quarter since 2007. Jim Cramer is chomping at the bit to buy more, and thinks it's about to roar.

  • Dow Chemical said it was looking to cut fixed costs by $1 billion over the next three years, building on reductions that have helped boost margins.

  • Dow Chemical CEO: The US has been a bright spot

    Dow investors have been rewarded in the last 3 months with stocks surging more than 20 percent. Andrew Liveris, Dow Chemical chairman and CEO, provides his outlook on the global economy and discusses the biggest opportunities for growth in Dow Chemical.